Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

Table 2

Regression summary for dependent variable: relative MAs in DCP for and groups.

(a)

	; ; adjusted; ; ; Std. error of estimate: 23.721
		Std.Err.		Std.Err.	(27)	value
Intercept			-5.02	10.76	-0.47	0.64
CMT relative	0.13	0.29	0.29	0.66	0.44	0.67
ETDRS %	-0.21	0.23	-0.94	1.04	-0.90	0.37
FAZ SCP %	0.34	0.15	0.23	0.11	2.20	0.04
FAZ DCP %	0.12	0.19	0.06	0.10	0.61	0.54
Density %	-0.32	0.15	-0.30	0.14	-2.09	0.05
Density sup %	0.17	0.19	0.79	0.87	0.90	0.37
Density inf %	-0.45	0.21	-1.31	0.59	-2.21	0.04
Density nasal%	0.18	0.16	1.03	0.91	1.13	0.27
Density temporal%	0.13	0.18	0.59	0.87	0.68	0.50

(b)

	; ; ; ; Std. error of estimate: 29.124
		Std.Err.		Std.Err.	(30)	value
Intercept			1.24	10.34	0.12	0.91
CMT relative	0.58	0.24	1.03	0.43	2.37	0.02
ETDRS %	0.11	0.23	0.36	0.77	0.47	0.64
FAZ SCP %	-0.14	0.19	-0.10	0.14	-0.72	0.48
FAZ DCP %	-0.36	0.24	-0.20	0.13	-1.50	0.14
Density %	-0.12	0.18	-0.41	0.63	-0.65	0.52
Density sup %	0.26	0.19	0.90	0.65	1.39	0.17
Density inf %	-0.45	0.20	-1.53	0.67	-2.28	0.03
Density nasal%	0.17	0.28	1.05	1.69	0.62	0.54
Density temporal%	-0.27	0.25	-1.78	1.65	-1.08	0.29